Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Schizophrenia Research

• Publication date

  2011-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2011.07.019PMID 21820875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

  2013cited by this paper
• Representations of medication and treatment: Advances in theory and measurement

  2013cited by this paper
• Do Patients With Schizophrenia Distinguish Between Attitudes Toward Antipsychotic Medication and Pharmacotherapy in General?: Validation of the Beliefs About Medication Questionnaire

  2012cited by this paper
• Interventions for latent autoimmune diabetes (LADA) in adults.

  2011cited by this paper
• How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.

  2011cited by this paper
• Early risk factors for suicide in an epidemiological first episode psychosis cohort.

  2011cited by this paper
• Patient participation in antipsychotic drug choice decisions.

  2010cited by this paper
• Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis

  2010cited by this paper
• Global Assessment of Functioning

  2010cited by this paper
• Medication Adherence in Outpatients With Severe Mental Disorders: Relation Between Self-Reports and Serum Level

  2010cited by this paper
• Measurement of psychiatric treatment adherence.

  2010cited by this paper
• [Insight into illness: an overview of the concept focusing on schizophrenia].

  2010cited by this paper
• Methodological challenges in psychiatric treatment adherence research.

  2010influential reference
• Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia.

  2010cited by this paper
• Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.

  2009influential reference
• Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

  2009influential reference
• Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders.

  2009influential reference
• Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework.

  2009cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

  2009cited by this paper
• The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

  2009cited by this paper
• Implicit versus explicit attitudes toward psychiatric medication: Implications for insight and treatment adherence.

  2009cited by this paper
• The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

  2009cited by this paper
• Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders

  2009cited by this paper
• Self‐stigma and the “why try” effect: impact on life goals and evidence‐based practices

  2009cited by this paper
• Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables.

  2009cited by this paper
• Assessment of Medication Adherence in Patients With Schizophrenia: The Achilles Heel of Adherence Research

  2008cited by this paper
• The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.

  2008influential reference
• Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.

  2008influential reference
• Adherence behaviour with psychotropic medication is a form of self-medication.

  2007cited by this paper
• The Differentiation between ‘Lack of Insight’ and ‘Dysfunctional Health Beliefs’ in Schizophrenia

  2007cited by this paper
• Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis.

  2007influential reference
• Insight, distress and coping styles in schizophrenia

  2007cited by this paper
• Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

  2007cited by this paper
• Lack of Insight in Schizophrenia

  2007cited by this paper
• Understanding and addressing adherence issues in schizophrenia: from theory to practice.

  2007cited by this paper
• Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia.

  2007cited by this paper
• Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders.

  2006cited by this paper
• Shared decision making and medication management in the recovery process.

  2006cited by this paper
• Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.

  2006cited by this paper
• Reporting Structural Equation Modeling and Confirmatory Factor Analysis Results: A Review

  2006influential reference
• Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.

  2006cited by this paper
• Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

  2006influential reference
• Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

  2005influential reference
• Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

  2005cited by this paper
• Pharmacological treatment for psychotic depression.

  2005cited by this paper
• Adherence to Maintenance-Phase Antidepressant Medication as a Function of Patient Beliefs About Medication

  2005cited by this paper
• Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.

  2004cited by this paper
• Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

  2004influential reference
• Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.

  2004cited by this paper
• Off-Label indications for atypical antipsychotics: a systematic review

  2003cited by this paper
• A review of the role of illness models in severe mental illness.

  2003cited by this paper
• How often do patients with psychosis fail to adhere to treatment programmes? A systematic review

  2003cited by this paper
• Insight in schizophrenia: a meta-analysis.

  2003cited by this paper
• Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.

  2003cited by this paper
• Compliance therapy: a randomised controlled trial in schizophrenia

  2003cited by this paper
• Principles and practice in reporting structural equation analyses.

  2002cited by this paper
• SUBJECTIVE ILLNESS THEORY AND ANTIPSYCHOTIC MEDICATION COMPLIANCE BY PATIENTS WITH SCHIZOPHRENIA

  2002cited by this paper
• Pharmacological treatment of psychotic depression

  2002cited by this paper
• A new scale (SES) to measure engagement with community mental health services

  2002influential reference
• To Parcel or Not to Parcel: Exploring the Question, Weighing the Merits

  2002cited by this paper
• Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

  2002cited by this paper
• Item Parceling Strategies in SEM: Investigating the Subtle Effects of Unmodeled Secondary Constructs

  1999cited by this paper
• Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives

  1999influential reference
• Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.

  1999cited by this paper
• The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication

  1999cited by this paper
• Perceptions of Health and Illness: Current Research and Applications

  1997cited by this paper
• Applications of structural equation modeling in marketing and consumer research: A review

  1996cited by this paper
• Psychopathological dimensions in schizophrenia.

  1995cited by this paper
• Global assessment of functioning. A modified scale.

  1995cited by this paper
• Assessment of insight in psychosis.

  1993cited by this paper
• A two-year prospective study of treatment compliance in patients with schizophrenia

  1992cited by this paper
• STRUCTURAL EQUATION MODELING IN PRACTICE: A REVIEW AND RECOMMENDED TWO-STEP APPROACH

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

  1986cited by this paper
• Evaluating structural equation models with unobservable variables and measurement error.

  1981cited by this paper

• Staff’s Countertransference and Implicit Attitudes Toward Insight in Psychotic Disorders – Do We Prefer Psychotic Patients with Insight?

  2026cites this paper
• Psychotropic medication non-adherence and its determinants among people living with mental illnesses in Ethiopia: systematic review and meta-analysis study

  2025cites this paper
• Structural Equation Modelling to Identify Psychometric Determinants of Medication Adherence in a Survey of Kidney Dialysis Patients

  2024cites this paper
• Evaluation of the Relationship between Disability and Disease Severity, Cognitive Functions, and Insight in Patients with Schizophrenia

  2024cites this paper
• Identifying the psychological effects of nocebo education: results from two pre-registered experiments

  2024cites this paper
• Differences in schizophrenia treatments by race and ethnicity—analysis of electronic health records

  2024cites this paper
• Attitudes towards Medication Intake in Patients with Mental Illness are influenced by Their Own and Relatives’ Beliefs about Medication

  2024cites this paper
• The attitude of healthcare providers towards medication self-management in hospitalised patients diagnosed with schizophrenia or bipolar disorders.

  2023cites this paper
• Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset

  2023cites this paper
• Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study

  2023cites this paper
• Medication Nonadherence and Risk of Violence to Others Among Patients With Schizophrenia in Western China

  2023cites this paper
• Functional and clinical outcomes of delusional disorder and schizophrenia patients after first episode psychosis: a 4-year follow-up study

  2023cites this paper
• Metacognition and insight dynamics exploration in borderline personality disorder: Exploring the underlying dynamics.

  2023cites this paper
• Prescribing and deprescribing trends in schizophrenia: An overview of inpatients in Belgium and in the Canadian province of Québec

  2023cites this paper
• Why using “consciousness” in psychotherapy? Insight, metacognition and self-consciousness

  2023cites this paper
• [Compliance and insight as factors of recovery in patients with schizophrenia spectrum disorders].

  2022cites this paper
• A scoping review: Treatment attitudes and adherence for adults with schizophrenia.

  2022cites this paper
• UKnowledge UKnowledge

  2022cites this paper
• Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature

  2022cites this paper
• A Randomized Controlled Trial of the Effects of Early Intervention Services On Insight in First Episode Psychosis.

  2022cites this paper
• Influence of teachers attitude on ict implementation in kenyan universities

  2022cites this paper
• Improving Medication Adherence in Community-Dwelling Patients with Schizophrenia Through Therapeutic Alliance and Medication Attitude: A Serial Multiple Mediation Model

  2022cites this paper
• Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis

  2022cites this paper
• A mixed methods study examining perceptions by service-users of their involuntary admission in relation to levels of insight

  2021cites this paper
• Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use.

  2021cites this paper
• A rating scale to inform successful discontinuation of antipsychotics and antidepressants.

  2021cites this paper
• Insight's level in borderline personality disorder, questioning consciousness

  2021cites this paper
• The attitude and prevalence of patient noncompliance toward chronic disease medications in Saudi Arabia

  2021cites this paper
• Personalizing interventions using real-world interactions: Improving symptoms and social functioning in schizophrenia with tailored metacognitive therapy.

  2021cites this paper
• Attitude Towards Drug Therapy in a Community Mental Health Center Evaluated by the Drug Attitude Inventory

  2020cites this paper
• Influence of demographic profile and symptoms on insight among people with schizophrenia

  2020cites this paper
• Enabling patients to cope with psychotropic medication in mental health care

  2020cites this paper
• Targeting the problem of treatment non-adherence among mentally ill patients: The impact of loss, grief and stigma.

  2020influential citation
• The Antipsychotic Medication Management Fidelity Scale: Psychometric properties

  2020cites this paper
• PPA_A_251993 995..1010

  2020cites this paper
• ADDRESSING FORMAL THOUGHT DISORDER IN PSYCHOSIS THROUGH NOVEL ASSESSMENT AND TARGETED INTERVENTION

  2020cites this paper
• Impulsivity issues in borderline personality disorder and it's links with insight: the role of urgency

  2019cites this paper
• The Insight Paradox among Outpatients with Schizophrenia

  2019cites this paper
• Thought disorder in atypical schizophrenia-like psychosis after stroke: analysis of clinical cases

  2019cites this paper
• Cognitive deficits, depressive symptoms, insight, and medication adherence in remitted patients with schizophrenia

  2019cites this paper
• Descriptive study of homeless patients' perceptions that affect medication adherence.

  2019cites this paper
• Illness Insight and Antipsychotic Medication Adherence

  2019cites this paper
• treatment adherence in schizophrenia: a literature review

  2018cites this paper
• Consumer satisfaction with antipsychotic medication-monitoring appointments: the role of consumer–prescriber communication patterns

  2018cites this paper
• The effect of motivational interviews on treatment adherence and insight levels of patients with schizophrenia: A randomized controlled study

  2018cites this paper
• Adesão à terapêutica nos doentes com esquizofrenia: uma revisão da literatura

  2018cites this paper
• The Multiple Dimensions of Insight in Schizophrenia-Spectrum Disorders

  2018cites this paper
• Adherence, insight and disability in paranoid schizophrenia.

  2018cites this paper
• Relationship Between Insight, Adherence and Disability in the Diagnose of Paranoid Schizophrenia

  2018cites this paper
• Subjectivity as “evidence”: an exploration of medication adherence in the treatment of schizophrenia using in-depth interviews

  2018cites this paper
• Self-Stigma Experiences Among Older Adults with Mental Health Problems Residing in Long-Term Care Facilities: A Qualitative Study

  2018cites this paper
• The mediating effect of family function and medication adherence between symptoms and mental disability among Chinese patients with schizophrenia: a cross-sectional study

  2018cites this paper
• [Icelanders' beliefs about medicines. Use of BMQ].

  2017cites this paper
• Evidenzbasierte Interventionen in der frühen Entwicklungsphase schizophrener Störungen

  2017cites this paper
• Relationship between insight and theory of mind in schizophrenia: A meta-analysis.

  2017cites this paper
• Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

  2017cites this paper
• Exploratory analysis of the French version of the beliefs about medicines questionnaire in patients with severe mental disorders: Factorial structure and reliability in specific populations of schizophrenic, bipolar and depressive patients

  2017cites this paper
• Meaning of resilience as described by people with schizophrenia†

  2017cites this paper
• Neuropsycological Function, Insight, and Treatment Adherence among Patients with Schizophrenia

  2017cites this paper
• Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care.

  2017cites this paper
• Families and medication use and adherence among Latinos with schizophrenia

  2017cites this paper
• Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics

  2017cites this paper
• Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening Tool.

  2017cites this paper
• Diagnósticos de enfermagem num serviço de urgência psiquiátrica: contributos para a sistematização dos cuidados

  2017cites this paper
• Medication nonadherence among South American patients with schizophrenia

  2017cites this paper
• Schizophrenia and Other Psychotic Disorders ( J Csernansky , Section Editor ) Improving Treatment Adherence in Schizophrenia

  2016cites this paper
• The necessity-concerns framework predicts adherence to medication in multiple illness conditions: A meta-analysis.

  2016cites this paper
• Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia.

  2016cites this paper
• The impact of negative treatment experiences on persistent refusal of antipsychotics.

  2016cites this paper
• An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments

  2016cites this paper
• Clinical factors related to schizophrenia relapse

  2016cites this paper
• Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.

  2016cites this paper
• Impact of Psychoeducation on Knowledge of and Attitude Toward Medications in Clients With Schizophrenia and Schizoaffective Disorders.

  2016cites this paper
• The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schizoaffective disorder: An exploratory study.

  2016influential citation
• De behandeltrouw van Mexicaanse Amerikanen met schizofrenie verbeteren met behulp van de theorie van gepland gedrag

  2016cites this paper
• Impact of Distance, Diagnosis, and Demographics on Attendance for Rural Outpatient Treatment

  2016cites this paper
• Understanding medication nonadherence in a sample of Egyptian patients with schizophrenia in relation to illness severity and insight

  2016cites this paper
• Effectiveness of Adherence Therapy for People With Schizophrenia in Turkey: A Controlled Study.

  2016cites this paper
• Compliance

  2016cites this paper
• A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders.

  2015influential citation
• Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study

  2015influential citation
• Is good insight associated with depression among patients with schizophrenia? Systematic review and meta-analysis.

  2015cites this paper
• The relationship between insight and autobiographical memory for emotional events in schizophrenia.

  2015cites this paper
• Using the theory of planned behavior to improve treatment adherence in Mexican Americans with schizophrenia.

  2015cites this paper
• Adhärenz in der Psychopharmakologie

  2015cites this paper
• The relationship between cognitive insight and depression in psychosis and schizophrenia: a review and meta-analysis.

  2015cites this paper
• Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

  2015cites this paper
• Strategies to improve medication adherence in patients with schizophrenia: the role of support services

  2015cites this paper
• Exploring the relationship between health beliefs and medication adherence in individuals with asthma

  2015cites this paper
• Skills-based medication training program for patients with schizophrenic disorders: a rater-blind randomized controlled trial

  2015cites this paper
• Beliefs About GI Medications and Adherence to Pharmacotherapy in Functional GI Disorder Outpatients

  2015cites this paper
• The Effect of Internalized Stigma on the Adherence to Treatment in Patients With Schizophrenia.

  2015cites this paper
• The effectiveness of compliance therapy on drug attitude among schizophrenic patients: a systematic review

  2015cites this paper
• Choosing to use compared to taking medication: the meaning of medication as described by people who experience schizophrenia.

  2015influential citation
• Association of symptom severity, insight and increased pharmacologic side effects in acutely hospitalized patients with schizophrenia.

  2014cites this paper
• A Rasch analysis of a questionnaire designed to evaluate psychiatric patient attitudes and knowledge after attending a pharmacist-led patient medication education group.

  2014cites this paper
• Non-Pharmacological Strategies to Enhance Adherence and Continuity of Care in Schizophrenia

  2014cites this paper
• Medication Adherence and Patients Satisfaction among Psychiatric Outpatients in a Rural Nigerian Tertiary Healthcare Facility

  2014cites this paper
• Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.

  2014cites this paper
• The rational patient and beyond: implications for treatment adherence in people with psychiatric disabilities.

  2014cites this paper